These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10547195

  • 1. Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
    Mohammad RM, Li Y, Mohamed AN, Pettit GR, Adsay V, Vaitkevicius VK, Al-Katib AM, Sarkar FH.
    Pancreas; 1999 Nov; 19(4):353-61. PubMed ID: 10547195
    [Abstract] [Full Text] [Related]

  • 2. Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
    Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH.
    Pancreas; 1998 Jan; 16(1):19-25. PubMed ID: 9436858
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma.
    Mohammad RM, Pettit GR, Almatchy VP, Wall N, Varterasian M, Al-Katib A.
    Anticancer Drugs; 1998 Feb; 9(2):149-56. PubMed ID: 9510501
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine.
    Li Y, Singh B, Ali N, Sarkar FH.
    Int J Mol Med; 1999 Jun; 3(6):647-53. PubMed ID: 10341297
    [Abstract] [Full Text] [Related]

  • 10. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC, Chafe SC, Brown WS, Saberi S, Swayampakula M, Venkateswaran G, Nemirovsky O, Gillespie JA, Karasinska JM, Kalloger SE, Supuran CT, Schaeffer DF, Bashashati A, Shah SP, Topham JT, Yapp DT, Li J, Renouf DJ, Stanger BZ, Dedhar S.
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S.
    Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
    [Abstract] [Full Text] [Related]

  • 13. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.
    Réjiba S, Wack S, Aprahamian M, Hajri A.
    Cancer Sci; 2007 Jul; 98(7):1128-36. PubMed ID: 17489984
    [Abstract] [Full Text] [Related]

  • 14. A novel cell line and xenograft model of ampulla of Vater adenocarcinoma.
    Sorio C, Moore PS, Ennas MG, Tecchio C, Bonora A, Sartoris S, Balzarini P, Grigolato P, Scarpa A.
    Virchows Arch; 2004 Mar; 444(3):269-77. PubMed ID: 14677066
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.
    Leitner S, Sweeney K, Oberg D, Davies D, Miranda E, Lemoine NR, Halldén G.
    Clin Cancer Res; 2009 Mar 01; 15(5):1730-40. PubMed ID: 19223497
    [Abstract] [Full Text] [Related]

  • 19. Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy.
    Hasnis E, Alishekevitz D, Gingis-Veltski S, Bril R, Fremder E, Voloshin T, Raviv Z, Karban A, Shaked Y.
    Neoplasia; 2014 Jun 01; 16(6):501-10. PubMed ID: 24957319
    [Abstract] [Full Text] [Related]

  • 20. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
    Gao CC, Xu XL, Li F, Gong BG, Liu S, Cui YQ, Sun HC, Xu PY, Zheng YM, Jiang H.
    Tumour Biol; 2016 Jun 01; 37(6):7555-64. PubMed ID: 26684804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.